Chronically streptozocin-diabetic monkey does not closely mimic human diabetic neuropathy
Hiroshi Yasuda(Japan Bio Products (Japan)), Yasuteru Shigeta(Shiga University of Medical Science), Ikuo Hatanaka(Shiga University of Medical Science), Ryuichi Kikkawa(Shiga University of Medical Science), A Kashiwagi(Shiga University of Medical Science), Yoshiaki Taniguchi, Ken′ichirou Kosugi(Shiga University of Medical Science), Z. Huitian(Shiga University of Medical Science), Y. Harano(National Cerebral and Cardiovascular Center), Hisashi Hidaka(Kitasato University)
Cited by 10
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513